共 49 条
- [41] Pretreatment Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Are Prognostic for Survival in a Heavily Pretreated Group of Patients Receiving Stereotactic Body Radiation Therapy to the Lung for Recurrent and/or Metastatic Tumors [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E437 - E438
- [44] Dosimetric factors of stereotactic body radiation therapy for isolated spinal metastatic diseases: impact of distance from tumor target to spinal cord on planning dosimetry and low dose spillage restriction [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2840 - 2848
- [45] Dosimetric impact of intrafraction patient motion on MLC-based 3D-conformal spatially fractionated radiation therapy treatment of large and bulky tumors [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2024,
- [47] Outcomes of Stereotactic Radiation Therapy (SRT) for Primary and Metastatic Liver Tumors with 3-D CT and Single Photon Emission Computed Tomography (3D-CT/SPECT) Treatment Planning [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S11 - S11
- [48] Preliminary Results in the Treatment of Recurrent Non-small Cell Lung Cancer (NSCLC) with Stereotactic Body Radiation Therapy (SBRT): Does Total Dose and Tumor Volume Impact Local Control? [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S508 - S508